Loading...

Dynatronics

BST:DYXA
Snowflake Description

Excellent balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
DYXA
BST
$13M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. The last earnings update was 68 days ago. More info.


Add to Portfolio Compare Print
  • Dynatronics has significant price volatility in the past 3 months.
DYXA Share Price and Events
7 Day Returns
-5.3%
BST:DYXA
3.6%
DE Medical Equipment
-0.7%
DE Market
1 Year Returns
-44.7%
BST:DYXA
7.4%
DE Medical Equipment
-7.6%
DE Market
DYXA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Dynatronics (DYXA) -5.3% -1.3% -25.2% -44.7% -44.1% -
DE Medical Equipment 3.6% -2.1% 4.8% 7.4% 112.8% 263.8%
DE Market -0.7% -0.9% -3.8% -7.6% 8.2% 11.1%
1 Year Return vs Industry and Market
  • DYXA underperformed the Medical Equipment industry which returned 7.4% over the past year.
  • DYXA underperformed the Market in Germany which returned -7.6% over the past year.
Price Volatility
DYXA
Industry
5yr Volatility vs Market

DYXA Value

 Is Dynatronics undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Dynatronics to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Dynatronics.

BST:DYXA Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 4 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.5%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BST:DYXA
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.87
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.87 (1 + (1- 21%) (65.29%))
1.213
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.21
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (1.213 * 5.96%)
7.46%

Discounted Cash Flow Calculation for BST:DYXA using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Dynatronics is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

BST:DYXA DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.46%)
2020 3.48 Est @ 78.65% 3.24
2021 5.40 Est @ 55.12% 4.67
2022 7.48 Est @ 38.66% 6.03
2023 9.51 Est @ 27.13% 7.13
2024 11.32 Est @ 19.06% 7.90
2025 12.84 Est @ 13.41% 8.34
2026 14.06 Est @ 9.45% 8.50
2027 15.00 Est @ 6.69% 8.43
2028 15.71 Est @ 4.75% 8.22
2029 16.24 Est @ 3.39% 7.91
Present value of next 10 years cash flows $70.38
BST:DYXA DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $16.24 × (1 + 0.23%) ÷ (7.46% – 0.23%)
$225.13
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $225.13 ÷ (1 + 7.46%)10
$109.66
BST:DYXA Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $70.38 + $109.66
$180.03
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $180.03 / 8.42
$21.39
BST:DYXA Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in BST:DYXA represents 0.83516x of NasdaqCM:DYNT
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.83516x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 21.39 x 0.83516
€17.86
Value per share (EUR) From above. €17.86
Current discount Discount to share price of €1.28
= -1 x (€1.28 - €17.86) / €17.86
92.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Dynatronics is available for.
Intrinsic value
>50%
Share price is €1.28 vs Future cash flow value of €17.86
Current Discount Checks
For Dynatronics to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Dynatronics's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Dynatronics's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Dynatronics's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Dynatronics's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BST:DYXA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-0.25
NasdaqCM:DYNT Share Price ** NasdaqCM (2019-07-19) in USD $1.53
Germany Medical Equipment Industry PE Ratio Median Figure of 10 Publicly-Listed Medical Equipment Companies 31.82x
Germany Market PE Ratio Median Figure of 422 Publicly-Listed Companies 19.75x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Dynatronics.

BST:DYXA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:DYNT Share Price ÷ EPS (both in USD)

= 1.53 ÷ -0.25

-6.24x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dynatronics is loss making, we can't compare its value to the DE Medical Equipment industry average.
  • Dynatronics is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Dynatronics's expected growth come at a high price?
Raw Data
BST:DYXA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -6.24x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
44.7%per year
Germany Medical Equipment Industry PEG Ratio Median Figure of 7 Publicly-Listed Medical Equipment Companies 2.49x
Germany Market PEG Ratio Median Figure of 270 Publicly-Listed Companies 1.44x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Dynatronics, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Dynatronics's assets?
Raw Data
BST:DYXA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $1.11
NasdaqCM:DYNT Share Price * NasdaqCM (2019-07-19) in USD $1.53
Germany Medical Equipment Industry PB Ratio Median Figure of 13 Publicly-Listed Medical Equipment Companies 4.12x
Germany Market PB Ratio Median Figure of 570 Publicly-Listed Companies 1.71x
BST:DYXA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:DYNT Share Price ÷ Book Value per Share (both in USD)

= 1.53 ÷ 1.11

1.38x

* Primary Listing of Dynatronics.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dynatronics is good value based on assets compared to the DE Medical Equipment industry average.
X
Value checks
We assess Dynatronics's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Dynatronics has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

DYXA Future Performance

 How is Dynatronics expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
44.7%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Dynatronics expected to grow at an attractive rate?
  • Dynatronics's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Dynatronics's earnings growth is expected to exceed the Germany market average.
  • Dynatronics's revenue growth is positive but not above the Germany market average.
Annual Growth Rates Comparison
Raw Data
BST:DYXA Future Growth Rates Data Sources
Data Point Source Value (per year)
BST:DYXA Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts 44.7%
BST:DYXA Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 4 Analysts 2%
Germany Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 12.7%
Germany Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 6.3%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.5%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BST:DYXA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BST:DYXA Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-06-30 68 1 1
2021-06-30 64 1 -1 3
2020-06-30 62 0 -1 4
2019-06-30 62 2 -2 4
BST:DYXA Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 64 2 -2
2018-12-31 66 0 -3
2018-09-30 69 0 -3
2018-06-30 64 1 -3
2018-03-31 59 -1 -5
2017-12-31 50 0 -5
2017-09-30 40 -1 -4
2017-06-30 36 -2 -4
2017-03-31 33 -1 -3
2016-12-31 32 0 -3
2016-09-30 31 0 -2
2016-06-30 30 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Dynatronics's earnings are expected to grow significantly at over 20% yearly.
  • Dynatronics's revenue is expected to grow by 2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BST:DYXA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from Dynatronics Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:DYXA Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-06-30 0.05 0.05 0.05 1.00
2021-06-30 -0.12 -0.05 -0.17 3.00
2020-06-30 -0.15 -0.10 -0.19 4.00
2019-06-30 -0.23 -0.22 -0.25 4.00
BST:DYXA Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -0.25
2018-12-31 -0.34
2018-09-30 -0.45
2018-06-30 -0.53
2018-03-31 -0.95
2017-12-31 -1.07
2017-09-30 -1.08
2017-06-30 -1.36
2017-03-31 -1.06
2016-12-31 -0.98
2016-09-30 -0.87
2016-06-30 -0.84

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Dynatronics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Dynatronics's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Dynatronics has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

DYXA Past Performance

  How has Dynatronics performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Dynatronics's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Dynatronics does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Dynatronics's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Dynatronics's 1-year growth to the DE Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Dynatronics's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Dynatronics Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:DYXA Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 63.96 -2.00 20.05 0.19
2018-12-31 66.04 -2.71 20.68 0.42
2018-09-30 68.68 -3.38 21.06 0.95
2018-06-30 64.41 -3.50 19.50 1.19
2018-03-31 58.68 -5.28 17.46 1.31
2017-12-31 49.76 -4.66 15.24 1.30
2017-09-30 40.39 -3.91 12.98 1.05
2017-06-30 35.76 -4.29 11.92 1.08
2017-03-31 32.72 -3.06 12.22 1.12
2016-12-31 32.42 -2.74 11.69 1.14
2016-09-30 31.18 -2.39 11.31 1.08
2016-06-30 30.41 -2.27 10.90 1.07
2016-03-31 30.19 -5.06 9.83 1.01
2015-12-31 29.47 -4.74 9.42 0.99
2015-09-30 29.30 -4.66 9.33 0.98
2015-06-30 29.12 -4.36 9.23 0.93
2015-03-31 28.27 -0.35 9.12 0.91
2014-12-31 27.76 -0.30 9.15 0.89
2014-09-30 27.61 -0.12 9.09 0.89
2014-06-30 27.44 -0.27 9.21 0.99
2014-03-31 27.57 -0.30 9.39 1.07
2013-12-31 28.45 -0.20 9.53 1.13
2013-09-30 29.31 -0.10 9.78 1.17
2013-06-30 29.46 -0.04 9.86 1.12
2013-03-31 30.01 0.14 9.87 1.09
2012-12-31 30.60 0.09 10.15 1.18
2012-09-30 30.87 -0.01 10.27 1.32

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Dynatronics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Dynatronics has efficiently used its assets last year compared to the DE Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Dynatronics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Dynatronics's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Dynatronics has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

DYXA Health

 How is Dynatronics's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Dynatronics's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Dynatronics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Dynatronics's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Dynatronics's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Dynatronics Company Filings, last reported 3 months ago.

BST:DYXA Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 20.87 5.14 0.41
2018-12-31 21.35 5.53 0.52
2018-09-30 21.74 5.46 0.44
2018-06-30 21.38 6.75 1.70
2018-03-31 21.97 7.05 1.50
2017-12-31 23.15 7.29 3.65
2017-09-30 12.59 7.68 5.55
2017-06-30 12.32 2.79 0.25
2017-03-31 5.72 3.19 3.35
2016-12-31 6.24 0.61 1.67
2016-09-30 5.37 0.64 0.87
2016-06-30 5.59 0.69 0.97
2016-03-31 6.61 0.72 1.08
2015-12-31 7.01 1.45 2.13
2015-09-30 7.14 1.46 2.08
2015-06-30 7.31 2.68 3.93
2015-03-31 5.76 2.69 0.34
2014-12-31 5.95 2.36 0.20
2014-09-30 6.07 2.05 0.68
2014-06-30 6.01 5.08 0.33
2014-03-31 6.04 5.31 0.13
2013-12-31 6.18 5.40 0.42
2013-09-30 6.12 5.42 0.22
2013-06-30 6.21 5.38 0.30
2013-03-31 6.26 5.84 0.17
2012-12-31 6.40 5.81 0.41
2012-09-30 6.24 5.89 0.29
  • Dynatronics's level of debt (40.3%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (87.9% vs 40.3% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Dynatronics has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Dynatronics has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -78.9% per year.
X
Financial health checks
We assess Dynatronics's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Dynatronics has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

DYXA Dividends

 What is Dynatronics's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Dynatronics dividends.
If you bought €2,000 of Dynatronics shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Dynatronics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Dynatronics's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BST:DYXA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
Germany Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 325 Stocks 3.2%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BST:DYXA Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2022-06-30
2021-06-30
2020-06-30
2019-06-30

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Dynatronics has not reported any payouts.
  • Unable to verify if Dynatronics's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Dynatronics's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Dynatronics has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Dynatronics's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Dynatronics afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Dynatronics has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

DYXA Management

 What is the CEO of Dynatronics's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Chris Von Jako
COMPENSATION $255,141
AGE 49
TENURE AS CEO 1.1 years
CEO Bio

Dr. Christopher Richard Von Jako, also known as Chris, Ph.D., has been Chief Executive Officer and Director of Dynatronics Corporation since June 26, 2018. Dr. Von Jako serves as Board Member of nView Medical Inc. He served as Chief Executive Officer and President of NinePoint Medical, Inc. since December 4, 2014 to June 2018. Dr. Von Jako served as Chief Executive Officer and President of NeuroTherm, Inc. since May 2013. Dr. Von Jako has over 20 years of leadership success and experience in the global medical device market with a specific expertise in minimal invasive surgery. He has spent the past 25 years focusing on the development and commercialization of image-guided techniques to improve patient experience and outcomes. Since 2010 until he assisted in the divesture in 2013, Dr. von Jako was the President of ActiViews, Ltd., a privately held high technical medical device company, which developed and marketed minimally invasive tools for Interventional Radiology. Previously, he served as Vice President of Marketing for the NeuroScience division at Integra LifeSciences from 2006 to 2010. Dr. von Jako served in senior executive roles of progressive responsibility with Integra LifeSciences, Covidien, Medtronic, and Radionics. He served as General Manager of Integra Burlington MA, Inc. He joined Integra as part of his successful divestiture of the Radionics business unit from Covidien, where Dr. von Jako was the General Manager from 2003 to 2006. Prior to this, he also worked as a Group Director at Medtronic Navigation after successfully assisting in the orchestration of a strategic collaboration with Odin Medical Technologies, where he was the General Manager and Executive Vice President. Dr. von Jako began his career with Radionics, where he held various leadership positions including Director of International Sales and Marketing, Director of Worldwide Neurosurgical Sales, and Director of European Operations. Dr. von Jako earned a Doctor of Philosophy degree in Biomedical Sciences from the University of Pécs Medical School (Pécs, Hungary), a Master of Science degree in Radiological Sciences and Technology from the department of Nuclear Engineering from the Massachusetts Institute of Technology (Cambridge, Massachusetts), and a double Bachelor of Science degree in Physics and Mathematics from Bates College (Lewiston, Maine).

CEO Compensation
  • Insufficient data for Chris to compare compensation growth.
  • Chris's remuneration is about average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Dynatronics management team in years:

1.5
Average Tenure
52
Average Age
  • The average tenure for the Dynatronics management team is less than 2 years, this suggests a new team.
Management Team

Chris Von Jako

TITLE
CEO & Director
COMPENSATION
$255K
AGE
49
TENURE
1.1 yrs

David Wirthlin

TITLE
CFO & Secretary
COMPENSATION
$127K
AGE
58
TENURE
2.8 yrs

Brian Baker

TITLE
Chief Operating Officer
AGE
52
TENURE
0.2 yrs

Terry Atkinson

TITLE
Director of Accounting
COMPENSATION
$100K
AGE
66
TENURE
2.8 yrs

Daryl Connell

TITLE
Chief Information Officer
AGE
47
TENURE
1.4 yrs

Skyler Black

TITLE
Corporate Controller
AGE
36
TENURE
1.5 yrs

Mark Crockett

TITLE
Consultant
AGE
53
Board of Directors Tenure

Average tenure and age of the Dynatronics board of directors in years:

3.6
Average Tenure
58
Average Age
  • The tenure for the Dynatronics board of directors is about average.
Board of Directors

Erin Enright

TITLE
Chairman of the Board
COMPENSATION
$52K
AGE
58
TENURE
1.4 yrs

Chris Von Jako

TITLE
CEO & Director
COMPENSATION
$255K
AGE
49
TENURE
1.1 yrs

Scott Klosterman

TITLE
Director
COMPENSATION
$52K
AGE
61
TENURE
3.6 yrs

David Holtz

TITLE
Director
COMPENSATION
$52K
AGE
53
TENURE
3.6 yrs

Kelvyn Cullimore

TITLE
Director
COMPENSATION
$1M
AGE
63
TENURE
36.3 yrs

R. Ward

TITLE
Director
COMPENSATION
$42K
AGE
63
TENURE
6.1 yrs

Brian Larkin

TITLE
Director
COMPENSATION
$42K
AGE
50
TENURE
4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Dynatronics's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Dynatronics has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

DYXA News

Simply Wall St News

DYXA Company Info

Description

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.

Details
Name: Dynatronics Corporation
DYXA
Exchange: BST
Founded: 1979
$11,477,964
8,417,793
Website: http://www.dynatronics.com
Address: Dynatronics Corporation
7030 Park Centre Drive,
Cottonwood Heights,
Utah, 84121,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM DYNT Common Stock Nasdaq Capital Market US USD 30. Nov 1983
BST DYXA Common Stock Boerse-Stuttgart DE EUR 30. Nov 1983
Number of employees
Current staff
Staff numbers
330
Dynatronics employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/21 23:59
End of day share price update: 2019/07/19 00:00
Last estimates confirmation: 2019/06/04
Last earnings filing: 2019/05/14
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.